Covered recipient · General Payments record
NATALIE VIERA FELICIANO
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2024
$278.25
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $278.25 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $46.70 | 3 |
| Amneal Pharmaceuticals LLC | $40.74 | 2 |
| BETA BIONICS, INC. | $39.69 | 2 |
| Amgen Inc. | $39.24 | 2 |
| Corcept Therapeutics | $33.50 | 2 |
| SANOFI-AVENTIS U.S. LLC | $33.17 | 1 |
| Alexion Pharmaceuticals, Inc. | $29.23 | 1 |
| Antares Pharma, Inc. | $15.98 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $278.25 | 14 |
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $29.23 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094014397 | CMS |
| Amgen Inc. | $14.71 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116195333 | CMS |
| Amgen Inc. | $24.53 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116195337 | CMS |
| Amneal Pharmaceuticals LLC | $18.60 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139204782 | CMS |
| Amneal Pharmaceuticals LLC | $22.14 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139204784 | CMS |
| Antares Pharma, Inc. | $15.98 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146491320 | CMS |
| BETA BIONICS, INC. | $19.75 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087886191 | CMS |
| BETA BIONICS, INC. | $19.94 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087886199 | CMS |
| Corcept Therapeutics | $19.26 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117773387 | CMS |
| Corcept Therapeutics | $14.24 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117773449 | CMS |
| Lilly USA, LLC | $15.76 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135233864 | CMS |
| Lilly USA, LLC | $13.92 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135236157 | CMS |
| Lilly USA, LLC | $17.02 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135236153 | CMS |
| SANOFI-AVENTIS U.S. LLC | $33.17 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139946561 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.